BackBlackRock Health Sciences Term Trust Overview
BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust Price to Sales

Latest P/S ratio for BlackRock Health Sciences Term Trust: 3.29 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Price to Sales

3.29

Price to Sales

3.29

Price-to-Sales ratio compares a company's stock price to its revenue per share. A lower P/S ratio may indicate that the stock is undervalued relative to its sales.

Price to Sales (Comparison Companies)

Loading

Price to Sales History

Loading

Price to Sales Comparison

Loading

BlackRock Health Sciences Term Trust (BMEZ) FAQ

BlackRock Health Sciences Term Trust (BMEZ) currently reports a P/S ratio of 3.29. That is below the sector sector average of 13.59. Use the charts on this page to explore BlackRock Health Sciences Term Trust's P/S ratio history and peer comparisons.

BlackRock Health Sciences Term Trust's P/S ratio of 3.29 is lower than the its sector sector average of 13.59. That is roughly 75.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/S ratio is a valuation multiple that relates BlackRock Health Sciences Term Trust's market price to a fundamental measure such as earnings, sales, or book value. At 3.29, BMEZ can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/S ratio of 3.29, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.59. From there, open related valuation or income-statement pages for BlackRock Health Sciences Term Trust, and consider following BMEZ for alerts when major investors trade the stock.